[Home](https://github.com/mm80843/T3.5/blob/pages/index.md) >> Class: [Risk](https://github.com/mm80843/T3.5/tree/pages/docs/Risk/index.md) >> Individual ID:PBN__Risk_6593 

# __Delay in the development of a commercially viable vaccine for covid-19__

## Articles mentionning the risk

* [Chamola_comprehensive_2020](https://github.com/mm80843/T3.5/blob/pages/Article/PBN__Article_430.md)

## Mitigations of this risk

* [Invest in expedited vaccine development, global collaboration, and resource allocation](https://github.com/mm80843/T3.5/blob/pages/Mitigation/PBN__Mitigation_8467.md)

## Name of the risk

Prolonged spread of the disease and increased infection rates

## People affected by this risk

* [And vulnerable communities](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_68.md)
* [Global population](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_278.md)
* [Healthcare workers](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_5552.md)

## Stakeholders who can mitigate this risk

* [And public health organizations](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_413.md)
* [Pharmaceutical companies](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_124.md)
* [Research institutions](https://github.com/mm80843/T3.5/blob/pages/Stakeholder/PBN__Stakeholder_2693.md)

## Technologies linked to the risk

* [And regulatory frameworks](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_2905.md)
* [Research funding](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_5481.md)
* [Vaccine development technologies](https://github.com/mm80843/T3.5/blob/pages/Technology/PBN__Technology_8007.md)

## This Risk belongs to this RiskGroup

* [Public health risks](https://github.com/mm80843/T3.5/blob/pages/RiskGroup/PBN__RiskGroup_3.md)

## This Risk belongs to this RiskSubgroup

* [Lack of effective medical solutions](https://github.com/mm80843/T3.5/blob/pages/RiskSubgroup/PBN__RiskSubgroup_37.md)

